Intro

This chapter explores a company's groundbreaking efforts in developing in vivo CAR T-cell therapies designed to bolster immune responses against cancer through a single gene therapy injection. It examines the current challenges in CAR T-cell treatments and outlines the potential impact of the company's recent advancements and clinical trials on cancer treatment.